Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Larnaudie

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 31, 2020
[PET technology: Latest advances and potential impact on radiotherapy]P Decazes, S Hapdey, A Larnaudie, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|April 20, 2023
Radiotherapy of skin adnexal carcinomaA Larnaudie, P Giraud, C Naessens, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 24, 2023
Management of head and neck carcinomas with synchronous or metachronous oligometastatic disease: Role of locoregional radiotherapy and metastasis-directed radiotherapyM Tonneau, R Nebbache, A Larnaudie, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 28, 2026
Discontinuation of the double-blind, placebo-controlled randomized, phase III GORTEC 2022-01 trial of radiotherapy-cetuximab and xevinapant in patients with locally advanced squamous cell carcinoma of the head and neck, unfit for cisplatinY Pointreau, A Larnaudie, X S Sun, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|October 27, 2023
[Last year of residency for radiation oncologists in France: Overview and perspectives]A Larnaudie, V Bourbonne, M Michalet, et al.
Cancer Medicine|December 16, 2024
Assessment and Prediction of Salivary Gland Function After Head and Neck Radiotherapy: A Systematic ReviewJ Le Guevelou, X Palard-Novello, E Kammerer, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 26, 2022
Interactions of radiation therapy with common and innovative systemic treatments: Antidiabetic treatments, antihypertensives, lipid-lowering medications, immunosuppressive medications and other radiosensitizing methodsY Zhou, A Larnaudie, Y Ghannam, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|December 26, 2021
Radiotherapy of salivary gland tumoursA Larnaudie, P-Y Marcy, N Delaby, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 13, 2020
[Impact of reconstructive or minimal invasive surgery on the assessment of current definitions of postoperative clinical target volume for head and neck cancers]S Racadot, B Vérillaud, A-A Serre, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|December 26, 2021
Radiotherapy of sinonasal cancersA Larnaudie, N Delaby, P-Y Marcy, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 31, 2020
[PET technology: Latest advances and potential impact on radiotherapy]P Decazes, S Hapdey, A Larnaudie, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|April 20, 2023
Radiotherapy of skin adnexal carcinomaA Larnaudie, P Giraud, C Naessens, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 24, 2023
Management of head and neck carcinomas with synchronous or metachronous oligometastatic disease: Role of locoregional radiotherapy and metastasis-directed radiotherapyM Tonneau, R Nebbache, A Larnaudie, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 28, 2026
Discontinuation of the double-blind, placebo-controlled randomized, phase III GORTEC 2022-01 trial of radiotherapy-cetuximab and xevinapant in patients with locally advanced squamous cell carcinoma of the head and neck, unfit for cisplatinY Pointreau, A Larnaudie, X S Sun, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|October 27, 2023
[Last year of residency for radiation oncologists in France: Overview and perspectives]A Larnaudie, V Bourbonne, M Michalet, et al.
Cancer Medicine|December 16, 2024
Assessment and Prediction of Salivary Gland Function After Head and Neck Radiotherapy: A Systematic ReviewJ Le Guevelou, X Palard-Novello, E Kammerer, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 26, 2022
Interactions of radiation therapy with common and innovative systemic treatments: Antidiabetic treatments, antihypertensives, lipid-lowering medications, immunosuppressive medications and other radiosensitizing methodsY Zhou, A Larnaudie, Y Ghannam, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|December 26, 2021
Radiotherapy of salivary gland tumoursA Larnaudie, P-Y Marcy, N Delaby, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 13, 2020
[Impact of reconstructive or minimal invasive surgery on the assessment of current definitions of postoperative clinical target volume for head and neck cancers]S Racadot, B Vérillaud, A-A Serre, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|December 26, 2021
Radiotherapy of sinonasal cancersA Larnaudie, N Delaby, P-Y Marcy, et al.
Pageof 2